EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Osteopontin in Chronic Inflammatory Diseases: Mechanisms, Biomarker Potential, and Therapeutic Strategies

Fuyuan Lang, Yuanheng Li, Ruizhe Yao, Meixiu Jiang

Biology · 16.04.2025 · 14 (4) · 428

DOI: 10.3390/biology14040428 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 16.04.2025. Verfasst von Fuyuan Lang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Queen Mary College, Jiangxi Medical College, Nanchang University, 999 Xuefu Road, Nanchang 330001, China. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China grants, Jiangxi province Science and Technology Program of the Health Commission, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic inflammatory diseases, such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), multiple sclerosis (MS), atherosclerosis, and inflammatory bowel disease (IBD), pose major global health concerns. These disorders are marked by persistent inflammation, immune system dysfunction, tissue injury, and fibrosis, ultimately leading to severe organ dysfunction and diminished quality of life. Osteopontin (OPN), a multifunctional extracellular matrix protein, plays a crucial role in immune regulation, inflammation, and tissue remodeling. It promotes immune cell recruitment, stimulates pro-inflammatory cytokine production, and contributes to fibrosis through interactions with integrins and CD44 receptors. Additionally, OPN activates key inflammatory pathways, including NF-κB, MAPK, and PI3K/Akt, further aggravating tissue damage in chronic inflammatory conditions. Our review highlights the role of OPN in chronic inflammation, its potential as a biomarker, and its therapeutic implications. We explore promising preclinical approaches, such as monoclonal antibodies, small molecule inhibitors, and natural compounds like curcumin, which have demonstrated potential in mitigating OPN-driven inflammation. However, challenges persist in selectively targeting OPN while maintaining its essential physiological roles, including bone remodeling and wound healing. Our review offers insights into therapeutic strategies and future research directions.

Schlagwörter

Stichwörter der Autor:innen

chronic inflammatory diseasesimmune regulationinflammatory signaling pathwayosteopontinpreclinical strategies

Autor:innen und Institutionen

  • Queen Mary College, Jiangxi Medical College, Nanchang University, 999 Xuefu Road, Nanchang 330001, China.
  • The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, 999 Xuefu Road, Nanchang 330031, China.

Förderung

  • National Natural Science Foundation of China grants
  • Jiangxi province Science and Technology Program of the Health Commission
  • National Natural Science Foundation of China

Zitieren

APA

Lang, F., Li, Y., Yao, R., & Jiang, M. (2025). Osteopontin in Chronic Inflammatory Diseases: Mechanisms, Biomarker Potential, and Therapeutic Strategies. Biology, 14(4), 428. https://doi.org/10.3390/biology14040428

Vancouver

Lang F, Li Y, Yao R, Jiang M. Osteopontin in Chronic Inflammatory Diseases: Mechanisms, Biomarker Potential, and Therapeutic Strategies. Biology. 2025;14(4):428. doi:10.3390/biology14040428

BibTeX
@article{Lang2025,
  author = {Lang, Fuyuan and Li, Yuanheng and Yao, Ruizhe and Jiang, Meixiu},
  title = {Osteopontin in Chronic Inflammatory Diseases: Mechanisms, Biomarker Potential, and Therapeutic Strategies},
  journal = {Biology},
  year = {2025},
  volume = {14},
  number = {4},
  pages = {428},
  doi = {10.3390/biology14040428}
}
Kostenlos starten →